Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (467)	10/5/2002 12:16:09 PM
From: Ken W	Respond to of 23958

Sergio "This post is about investing and using trading opportunities to keep yourself from depression while the market is snoring at unrecognized fundamentals. Trading is something that you, Ken have a master's degree in and should therefore be exploiting market opportunities as I am sure that you are doing. I look forward to your leadership in this regard on the Amigo thread. Perhaps you would like to add ORBT back in to this portfolio" I've been following exactly the theme that you describe except, I have not been trading too much for the last month. While Oct. historically has been a poor month to be in the market, this year looks a bit different, due to the ongoing war talk, scandels etc. This creates mass histeria (volatility). Having said that, I'm back in the saddle and ready to rumble. I will take my fast trades over to the amigos thread as you suggest as I know you want to keep this one for longer term FA type plays. Ken

To: Sergio H who wrote (467)	10/5/2002 6:45:25 PM
From: Arthur Radley	Respond to of 23958

What a horrendous market...DJIA down 6 weeks in a row and touching levels not seen for years. I'm pleased that one of my stocks is bucking this trend and that is ALTH. ALTH is a biotech firm with (1)a nice cash position($70M+) as of last Q.(2)Drug is in final stage of Phase III testing and on fast track approval with the FDA (3)And not like most biotechs, they still control 100% of the drug as they haven't formed any alliances as they have raised the aforementioned cash without such alliance partners (4)Latest data on drug is well about approval level criteria set with FDA trials biz.yahoo.com (5) Stock has traded UP for the past three weeks (6) As of Friday's close the stock broke ABOVE 50 DMA. (6) Several brokerage houses have recently issued buy reports (7)Institutional ownership well above 60% (8) Insider ownership is also high and one insider has been making huge purchases as of late. The market for this drug is HUGE and I do own a position in the stock. Check the data on institutional purchasing as of late....huge buying going on and note the % of the float.. biz.yahoo.com